Arch Iran Med. 25(8):577.
doi: 10.34172/aim.2022.92
Correction
Correction: A Trial on the Effects of Magnesium-Zinc-Calcium Vitamin D Co-supplementation on Glycemic Control and Markers of Cardio-metabolic Risk in Women with Polycystic Ovary Syndrome
Mehri Jamilian 1, Maryam Maktabi 1, Zatollah Asemi 2, *
Author information:
1Endocrinology and Metabolism Research Center, Department of Gynecology and Obstetrics, School of Medicine, Arak University of Medical Sciences, Arak, Iran
2Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran
Copyright and License Information
© 2022 The Author(s).
This is an open-access article distributed under the terms of the Creative Commons Attribution License (
https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article as: Jamilian M, Maktabi M, Asemi Z. Correction: A trial on the effects of magnesium-zinc-calcium vitamin d cosupplementation on glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome. Arch Iran Med. 2022;25(8):577. doi: 10.34172/aim.2022.92
This corrects the article: “A trial on the effects of magnesium-zinc-calcium vitamin D co-supplementation on glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome”1 published on “2017;20(10):640-645” in the Archives of Iranian Medicine journal.
In the original version of this article, participants was wrongly reported 60 in the results, while the correct participants is 30 in each group.
In addition, in the conclusions section, a citation from our previous paper was omitted. The correct conclusions are another article by Maktabi et al39 with the same clinical trial described identical study timelines, location, sample size, randomization methods showed that co-supplementation had beneficial effects on hormonal profiles, biomarkers of inflammation, and oxidative stress.
39. Maktabi M, Jamilian M, Asemi Z. Magnesium-Zinc-Calcium-Vitamin D Co-supplementation Improves Hormonal Profiles, Biomarkers of Inflammation and Oxidative Stress in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Biol Trace Elem Res. 2018 Mar; 182(1):21-28.
References
- Jamilian M, Maktabi M, Asemi Z. A trial on the effects of magnesium-zinc-calcium-vitamin D co-supplementation on glycemic control and markers of cardio-metabolic risk in women with polycystic ovary syndrome. Arch Iran Med 2017; 20(10):640-645. [ Google Scholar]